US approves Pfizer vaccine for ages 12-15

Updated May 11 2021 - 7:39am, first published 7:34am
The pace of US vaccinations has slowed significantly since peaking in mid-April.
The pace of US vaccinations has slowed significantly since peaking in mid-April.

US regulators have authorised Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination rates have slowed significantly.

Subscribe now for unlimited access.

or signup to continue reading

All articles from our website & app
The digital version of Today's Paper
Breaking news alerts direct to your inbox
Interactive Crosswords, Sudoku and Trivia
All articles from the other in your area

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.